[Hub]/) : Traits : Whole body fat-free mass :

chr2:231,628,878-234,434,621

Best TWAS P=1.05e-15 · Best GWAS P=2.97e-12 conditioned to 0.531

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 GTEx Brain Cerebellar Hemisphere PTMA 0.28 0.12 enet 19 0.06 1.5e-02 -5.4 5.5 3.3e-08 -0.48 0.05 0.52 FALSE
2 GTEx Brain Frontal Cortex BA9 C2orf82 0.24 0.16 lasso 10 0.12 3.9e-04 -4.8 5.6 1.7e-08 0.02 0.04 0.93 FALSE
3 GTEx Brain Putamen basal ganglia C2orf82 0.28 0.22 lasso 3 0.18 5.3e-05 -4.8 5.7 1.0e-08 0.01 0.04 0.78 FALSE
4 GTEx Heart Atrial Appendage COPS7B 0.22 0.01 lasso 6 0.01 1.3e-01 -5.4 -6.0 2.4e-09 0.66 0.05 0.23 FALSE
5 GTEx Liver PDE6D 0.21 0.10 lasso 4 0.09 1.8e-03 -7.0 -7.4 1.1e-13 0.81 0.01 0.90 TRUE
6 GTEx Thyroid GIGYF2 0.08 0.02 lasso 3 0.01 6.7e-02 -6.3 -5.6 1.7e-08 -0.02 0.06 0.49 FALSE
7 ROSMAP Brain Pre-frontal Cortex NCL 0.16 0.05 lasso 6 0.08 6.1e-10 3.9 6.4 1.8e-10 0.06 0.01 0.99 TRUE
8 ROSMAP Brain Pre-frontal Cortex LINC00471 0.34 0.26 lasso 10 0.36 2.1e-48 -5.9 5.2 1.7e-07 -0.04 0.18 0.82 FALSE
9 YFS Blood EIF4E2 0.06 0.04 enet 27 0.04 2.8e-13 4.6 5.2 2.4e-07 -0.04 1.00 0.00 FALSE
10 The Cancer Genome Atlas Bladder Urothelial Carcinoma C2orf52 0.15 0.14 enet 8 0.13 3.7e-11 -6.1 6.0 1.7e-09 -0.02 0.10 0.90 FALSE
11 The Cancer Genome Atlas Breast Invasive Carcinoma C2orf52 0.19 0.22 blup 42 0.25 4.1e-50 -5.9 5.1 3.0e-07 -0.02 0.07 0.93 FALSE
12 The Cancer Genome Atlas Breast Invasive Carcinoma DIS3L2 0.05 0.02 enet 10 0.02 3.8e-05 -3.4 -5.4 6.4e-08 0.15 0.10 0.02 TRUE
13 The Cancer Genome Atlas Cervical Squamous Cell Carcinoma C2orf52 0.28 0.12 lasso 6 0.12 2.0e-06 -6.4 6.5 8.6e-11 -0.04 0.02 0.98 FALSE
14 The Cancer Genome Atlas Colon Adenocarcinoma C2orf52 0.21 0.16 blup 42 0.24 7.1e-14 -5.9 6.1 1.4e-09 0.00 0.06 0.94 FALSE
15 The Cancer Genome Atlas Glioblastoma Multiforme C2orf52 0.28 0.12 enet 12 0.18 5.0e-06 -6.1 6.2 5.6e-10 -0.03 0.03 0.87 FALSE
16 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma C2orf52 0.23 0.25 enet 12 0.28 2.9e-32 -6.0 5.7 1.5e-08 -0.03 0.16 0.84 FALSE
17 The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma C2orf52 0.18 0.20 lasso 3 0.19 3.4e-11 -5.9 5.9 4.0e-09 -0.02 0.08 0.92 FALSE
18 The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma EFHD1 0.11 0.01 blup 70 0.03 1.0e-02 5.9 8.0 1.0e-15 -0.03 0.02 0.72 TRUE
19 The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma KCNJ13 0.07 0.06 enet 13 0.05 4.7e-04 -6.7 5.8 6.6e-09 0.01 0.02 0.92 FALSE
20 The Cancer Genome Atlas Brain Lower Grade Glioma C2orf82 0.14 0.20 enet 6 0.19 3.1e-21 -4.9 5.2 2.1e-07 0.01 1.00 0.00 FALSE
21 The Cancer Genome Atlas Brain Lower Grade Glioma GIGYF2 0.02 0.01 lasso 3 0.01 5.3e-02 -6.7 -6.8 1.2e-11 -0.02 0.03 0.88 FALSE
22 The Cancer Genome Atlas Brain Lower Grade Glioma NGEF 0.03 0.01 blup 130 0.01 2.0e-02 -6.7 5.7 1.5e-08 0.01 0.02 0.90 FALSE
23 The Cancer Genome Atlas Liver Hepatocellular Carcinoma C2orf52 0.13 0.06 lasso 4 0.05 2.1e-03 -6.1 6.0 2.2e-09 -0.03 0.03 0.56 FALSE
24 The Cancer Genome Atlas Lung Adenocarcinoma C2orf52 0.18 0.16 enet 12 0.19 3.0e-21 -6.1 5.4 6.7e-08 -0.03 0.08 0.92 FALSE
25 The Cancer Genome Atlas Lung Adenocarcinoma CHRNG 0.04 0.00 blup 58 0.00 1.3e-01 2.1 -5.2 2.2e-07 0.12 0.00 0.14 FALSE
26 The Cancer Genome Atlas Lung Squamous Cell Carcinoma C2orf52 0.28 0.18 lasso 4 0.20 3.7e-22 -6.4 6.1 1.4e-09 -0.05 0.02 0.98 FALSE
27 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma C2orf52 0.24 0.20 lasso 3 0.20 1.4e-13 -5.9 5.8 4.8e-09 -0.02 0.11 0.89 FALSE
28 The Cancer Genome Atlas Pancreatic Adenocarcinoma C2orf52 0.32 0.21 lasso 7 0.21 3.6e-09 -5.8 5.8 8.2e-09 -0.06 0.05 0.95 FALSE
29 The Cancer Genome Atlas Pancreatic Adenocarcinoma KCNJ13 0.07 0.07 blup 36 0.06 2.4e-03 -6.7 6.3 3.3e-10 0.02 0.01 0.87 FALSE
30 The Cancer Genome Atlas Pheochromocytoma and Paraganglioma C2orf52 0.27 0.27 lasso 5 0.28 1.7e-11 -6.1 6.1 8.1e-10 -0.01 0.07 0.93 FALSE
31 The Cancer Genome Atlas Prostate Adenocarcinoma C2orf52 0.32 0.34 blup 42 0.39 9.3e-44 -5.9 5.4 6.1e-08 0.00 0.03 0.97 FALSE
32 The Cancer Genome Atlas Prostate Adenocarcinoma GIGYF2 0.04 0.00 blup 103 0.02 2.1e-03 -4.9 -6.0 1.6e-09 0.01 0.04 0.81 FALSE
33 The Cancer Genome Atlas Skin Cutaneous Melanoma C2orf52 0.21 0.20 lasso 1 0.18 1.4e-05 -6.4 6.4 1.7e-10 -0.02 0.02 0.82 FALSE
34 The Cancer Genome Atlas Stomach Adenocarcinoma C2orf52 0.12 0.10 enet 11 0.12 5.6e-09 -5.9 5.7 1.5e-08 0.00 0.04 0.96 FALSE
35 The Cancer Genome Atlas Stomach Adenocarcinoma KCNJ13 0.09 0.06 blup 36 0.08 3.8e-06 -6.7 5.4 7.2e-08 0.02 0.01 0.98 FALSE
36 The Cancer Genome Atlas Testicular Germ Cell Tumors C2orf52 0.29 0.17 enet 10 0.19 3.2e-07 -6.1 5.9 2.9e-09 -0.04 0.04 0.94 FALSE
37 The Cancer Genome Atlas Thyroid Carcinoma C2orf52 0.45 0.31 enet 10 0.35 4.9e-35 -5.8 5.1 2.9e-07 -0.01 0.24 0.76 FALSE
38 The Cancer Genome Atlas Thyroid Carcinoma KCNJ13 0.03 0.00 blup 35 0.01 4.3e-02 6.0 -7.5 7.9e-14 -0.02 0.01 0.55 FALSE
39 The Cancer Genome Atlas Thyroid Carcinoma NGEF 0.04 0.03 enet 7 0.03 5.6e-04 6.0 -7.1 1.0e-12 0.00 0.04 0.93 FALSE